| PDF (473kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-254491
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.25449
Zusammenfassung
(+)-4-Propyl-9-hydroxynaphthoxazine (+PHNO) is a potent dopamine agonist that has been administered transdermally to four patients with Parkinson's disease and "on-off" fluctuations. Skin patches of increasing size were used to treat these patients, who also received infrequent doses of oral levodopa if required. The effect of +PHNO was measured as an increased duration of action of individual ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags